NCT06145386

Brief Summary

The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. In this context, the study was planned by including 15 participants between the ages of 18-25 who had COVID-19 and 15 who did not have COVID-19. Data were collected by applying the Personal Data Form, IPAQ (International Physical Activity Form), SF-36 Quality of Life Scale, Coronavirus Anxiety Scale (CCS), Respiratory Function Tests (PFT), Six Minute Walk Test (6MWT). Aerobic training and strengthening training were applied to people with and without COVID-19 for 12 weeks. Aerobic exercise (walking) was given for 40 minutes 5 days a week, with the target heart rate being 70% of the age-corrected maximum heart rate. Strengthening exercises were applied to the upper (triceps, biceps, deltoid, pectorals) and lower (quadriceps, hamstring, gastrocnemius, tibialis anterior, hip adductors, hip flexors, hip extensors) extremities and back muscles (trapezius, latissimus dorsi) with theraband (resistance band). Significance test of the difference between two means in comparing independent group differences when parametric test assumptions are met for statistical analysis in line with the data collected from the participants; When parametric test assumptions are not met, Mann Whitney U test is used to compare independent group differences, while when parametric test assumptions are met to examine dependent group differences, the significance test of the difference between the two spouses is used; When parametric test assumptions were not met, the Wilcoxon paired two sample test was used. In all analyses, p \< .05 was considered statistically significant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable covid19

Timeline
Completed

Started Feb 2022

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 24, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2024

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

November 22, 2023

Last Update Submit

January 21, 2025

Conditions

Keywords

aerobic exercise, strength training, pulmonary capacity

Outcome Measures

Primary Outcomes (5)

  • International Physical Activity Questionnaire

    Used to define participants physical activity level

    5 minute

  • SF-36

    Used to indicate the health status of participants

    10 minute

  • Coronavirus Anxiety Scale

    Used to evaluate experience some psychological problems such as anxiety and depression depends on COVID-19

    1 minute

  • Respiratory Function Tests

    Used to evaluation of the respiratory system

    5 minute

  • The 6 Minute Walk Test

    Used to assess aerobic capacity and endurance

    6 minute

Study Arms (2)

COVID-19 positive

EXPERIMENTAL
Behavioral: Aerobic Exercise and Strength Training

COVID-19 negative

EXPERIMENTAL
Behavioral: Aerobic Exercise and Strength Training

Interventions

Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19

COVID-19 negativeCOVID-19 positive

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteering to participate in the study,
  • Able to communicate, without hearing and/or visual impairment,
  • Being between the ages of 18-25
  • Not having a systemic disease
  • Having had COVID-19 in the last 6 months to be included in the study group

You may not qualify if:

  • Unable to communicate, hearing and/or visually impaired,
  • Not being between the ages of 18-25
  • Having a systemic disease other than COVID-19 infection,
  • Having had COVID-19 more than 6 months ago.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Aydin University

Istanbul, Kücükcekmece, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19

Interventions

ExerciseResistance Training

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, Human

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

November 22, 2023

First Posted

November 24, 2023

Study Start

February 21, 2022

Primary Completion

April 21, 2023

Study Completion

December 19, 2024

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

If there is a reasonable request.

Locations